Low-dose intra-arterial contrast-enhanced MR aortography in patients based on a theoretically derived injection protocol.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 15968517.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Multiple intra-arterial contrast agent injections are necessary during MR-guided endovascular interventions. In respect to the approved limits of maximum daily gadolinium dose, a low-dose injection protocol is mandatory. The objective of this study was to derive and apply a low-dose injection protocol for intra-arterial 3D contrast-enhanced MR aortography in patients. Injection rate (Qinj), concentration of injected gadolinium [Gd]inj and aortal blood flow rate (Qblood) were included for the theoretical evaluation of signal intensity (SI) of the arterial lumen. SI simulations were carried out at Qinj=2 versus 4 ml/s in the [Gd]inj range between 0-500 mM. Qinj and [Gd]inj with SI above the 75% threshold of the maximal SI were regarded as optimal injection parameters. [Gd]inj=50 mM and Qinj=4 ml/s were considered as optimal and were administered in five patients for 3D MR aortography. All images revealed clear delineation of the abdominal aorta and its major branches. Mean+/-SD of contrast-to-noise ratios of the abdominal aorta, common iliac and renal artery were 70.2+/-15.2, 58.6+/-12.3 and 67.4+/-12.3. Approximately seven intra-aortal injections would be permissible in patients during MR-guided interventions without exceeding the maximal dose of gadolinium.
Medical subject headings
- Aortography
- Contrast Media
- Gadolinium DTPA
- Imaging, Three-Dimensional
- Magnetic Resonance Angiography